Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Study of Lurbinectedin (PM01183) in Combination With Capecitabine in Patients With Metastatic Breast Cancer (MBC), Pancreatic Cancer (PC) or Metastatic Colorectal Cancer (CRC).
- Status
- COMPLETED
- Phase
- PHASE1
Paclitaxel in Combination With Carboplatin Versus Paclitaxel Plus Epirubicin in Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
ER Reactivation Therapy for Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Safety, Feasibility and Efficacy of Vitamin D Supplementation in Women With Metastatic Breast Cancer (SAFE-D)
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Efficacy Study of Eribulin in Combination With Bevacizumab for Second-line Treatment HER2- MBC Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine Versus the Combination of Trastuzumab Plus Docetaxel in Patients With HER2-positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE3
A Trial Comparing Docetaxel Plus Fulvestrant With Docetaxel in Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Anti-PD-1 Monoclonal Antibody in Advanced, Trastuzumab-resistant, HER2-positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Rapid Medical Donation Programme for Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
Clinical Utility of CTC Test in Medicare-Eligible Metastatic Breast Cancer Patients
- Status
- WITHDRAWN
- Phase
- N/A
Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane
- Status
- UNKNOWN
- Phase
- NA
A Study of Abemaciclib (LY2835219) In Participants With Previously Treated Breast Cancer That Has Spread
- Status
- COMPLETED
- Phase
- PHASE2
AURORA: Aiming to Understand the Molecular Aberrations in Metastatic Breast Cancer.
- Status
- RECRUITING
- Phase
- NA
Cardiotoxicity in Metastatic Her 2 Positive Patients Treated With Trastuzumab ,Pertuzumab and Taxanes
- Status
- UNKNOWN
- Phase
- N/A
BIG Molecular Screening Feasibility Study
- Status
- COMPLETED
- Phase
- NA
T-DM1 With Abraxane and Lapatinib for Metastatic HER2 Positive Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1